Discover 60 paid clinical trials in Idaho Falls, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 60
Active & Responsive
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
for
Influenza
Location: 15 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 11
Code: NCT06094010
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
for
Primary IgA Nephropathy
Location: 36 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05797610
Phase3, Recruiting
Active & Responsive
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
for
Viral Pneumonia
Location: 3 recruiting locations
Sponsor: Synairgen Research Ltd.
Sex: All
Age: 18+
Code: NCT06999603
Phase2, Recruiting
Active & Responsive
Innovative Automated Insulin Delivery System for Type 2 Diabetes
for
Type 2 Diabetes, Insulin Treated Type 2 Diabetes Mellitus
Location: 27 recruiting locations
Sponsor: Deka Research and Development
Sex: All
Age: 18+
Code: NCT06853990
Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: 79 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: 49 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06588855
Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: 80 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06589986
Phase3, Recruiting
Active & Responsive
Assessing Modified CBTi in Adults with Insomnia Disorder
for
Insomnia Disorder, Cognitive Functioning
Location: 1 recruiting location
Sponsor: Idaho State University
Sex: All
Age: 18+
Code: NCT06600516
Recruiting
A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: 12 recruiting locations
Sponsor: Diamyd Medical AB
Sex: All
Age: 12 - 28
Code: NCT05018585
Phase3, Recruiting
Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia